Compare OPTH & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | OPTH | ONMD |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 25.0M |
| IPO Year | 2024 | 2021 |
| Metric | OPTH | ONMD |
|---|---|---|
| Price | $3.25 | $4.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.4K | ★ 54.3K |
| Earning Date | 12-08-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,359,000.00 |
| Revenue This Year | $56.17 | N/A |
| Revenue Next Year | $82.70 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 111.35 |
| 52 Week Low | $3.04 | $0.63 |
| 52 Week High | $5.45 | $123.00 |
| Indicator | OPTH | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 27.97 | 30.48 |
| Support Level | $3.04 | $3.61 |
| Resistance Level | $5.21 | $35.00 |
| Average True Range (ATR) | 0.32 | 0.35 |
| MACD | -0.04 | 1.00 |
| Stochastic Oscillator | 10.00 | 72.34 |
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.